Drug manufacturer Amylyx pulls ALS drug Relyvrio from market, citing lack of efficacy
The following is from Public Citizen. Amylyx Pharmaceuticals said on Thursday that it would withdraw AMX0035 (sodium phenylbutyrate and taurursodiol, sold as Relyvrio) from the market. A large clinical trial recently found that the drug did not provide any benefit to patients […]
Drug manufacturer Amylyx pulls ALS drug Relyvrio from market, citing lack of efficacy Read More »
